Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$25.33 - $35.39 $103,853 - $145,099
4,100 Added 292.86%
5,500 $149,000
Q2 2024

Aug 14, 2024

SELL
$26.68 - $34.7 $216,108 - $281,070
-8,100 Reduced 85.26%
1,400 $40,000
Q1 2024

May 15, 2024

BUY
$24.99 - $33.01 $29,987 - $39,612
1,200 Added 14.46%
9,500 $277,000
Q4 2023

Feb 14, 2024

BUY
$23.4 - $35.39 $86,580 - $130,943
3,700 Added 80.43%
8,300 $269,000
Q3 2023

Nov 14, 2023

BUY
$32.0 - $44.97 $118,400 - $166,389
3,700 Added 411.11%
4,600 $147,000
Q2 2023

Aug 14, 2023

SELL
$41.38 - $51.98 $281,384 - $353,464
-6,800 Reduced 88.31%
900 $39,000
Q1 2023

May 15, 2023

SELL
$39.69 - $49.77 $55,566 - $69,678
-1,400 Reduced 15.38%
7,700 $341,000
Q4 2022

Feb 14, 2023

BUY
$36.59 - $48.33 $332,969 - $439,803
9,100 New
9,100 $361,000

Others Institutions Holding KIDS

About ORTHOPEDIATRICS CORP


  • Ticker KIDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,894,400
  • Market Cap $512M
  • Description
  • OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; a...
More about KIDS
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.